Prognostic Factors for Platinum-Chemotherapy Response and Survival Outcomes in Patients with Advanced Stage Non-Small Cell Lung Cancer

Targeted Therapy in Non-Small Cell Lung Cancer: Review Article

Second-Line Chemotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC): Single Institution Experience

IMPACT OF EGFR MUTATION ON PROGNOSIS OF STAGE IV NON-SQUAMOUS NON-SMALL CELL LUNG CANCER NSCLC: A RETROSPECTIVE ANALYSIS

Treatment Outcome in Patients with Metastatic Non-Small Cell Lung Cancer at Presentation (Retrospective Study)

Single Nucleotide Polymorphism of ERCC1 Gene in Patients with Non-Small Cell Lung Cancer and its Relation to the Response to Platinum Chemotherapy

Gefitinib in Non-Small Cell Lung Cancer: A Prospective Study at South Egypt Cancer Institute

COMPARISON BETWEEN CONCOMITANT CHEMO-RADIOTHERAPY WITH CISPLATIN VERSUS INDUCTION CHEMOTHERAPY FOLLOWED BY CONCOMITANT CHEMORADIOTHERAPY WITH CISPLATIN AND ETOPOSIDE REGIMEN IN C

Role of epidermal growth factor receptor inhibitors in the treatment of lung cancer

Correlation of Epidermal Growth Factor Receptor (EGFR), Mutation status and plasma level